Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Sunhydrogen, Inc. HYSR US Equity

Information Technology · CIK 1481028 · FY ends Jun 30
$0.02
+0.00 (+0.53%)
USD · as of 2026-08-28 · marketstack

Sunhydrogen, Inc. (OTC: HYSR), an SEC filer in Semiconductors & Related Devices, closed at $0.02, +0.5%, on 2026-08-28, with a market cap of $109M and a return on equity of -21.0%. Institutional ownership, earnings history and filed financials are on the tabs below.

HYSR · 10-K · period ended 2021-06-30

← all HYSR documents
filed 2021-10-08 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 1600 of 1,846142k characters rendered

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED JUNE 30, 2021

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________ TO __________

COMMISSION FILE NUMBER:

000-54437

SUNHYDROGEN, INC.

(Name of registrant in

its charter)

10 E. Yanonali St.,Suite 36Santa Barbara,CA93101

(Address of principal

executive offices) (Zip Code)

Issuer’s telephone

Number: (805)966-6566

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

None None None

Securities registered

pursuant to section 12(g) of the Act: common stock, par value $0.001 per share

Indicate by check mark

if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐No☒

Indicate by check mark

if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐No☒

Indicate by check

mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during

the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject

to such filing requirements for the past 90 days. Yes☒ No ☐

Indicate by check mark

whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit

such files). Yes☒ No ☐

Indicate by check mark

whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an

emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller

reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated Filer ☐

Non-accelerated filer ☒ Smaller reporting company ☒

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark

whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal

control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting

firm that prepared or issued its audit report. ☐

Indicate by check mark

whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐No☒

The aggregate market

value of the common stock held by non-affiliates of the registrant, based upon the last sale price of the common stock of the Company

as of the last business day of its most recently completed second fiscal quarter was approximately $267,705,946.

The number of shares of registrant’s

common stock outstanding, as of October 8, 2021 was 4,054,676,450.

DOCUMENTS

INCORPORATED BY REFERENCE

None

TABLE OF CONTENTS

Page

PART I

Item 1. Business 1

Item 1A. Risk Factors 6

Item 2. Properties 11

Item 3. Legal Proceedings 11

Item 4. Mine Safety Disclosures 11

PART II

Item 6. [Reserved.] 13

Item 7A. Quantitative and Qualitative Disclosures about Market Risk. 16

Item 8. Financial Statements and Supplementary Data 16

Item 9A. Controls and Procedures 16

Item 9B. Other Information. 17

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 17

PART III

Item 10. Directors, Executive Officers and Corporate Governance 18

Item 11. Executive Compensation 20

Item 14. Principal Accountant Fees and Services 23

Item 15. Exhibit and Financial Statement Schedules 24

SIGNATURES 26

i

PART I

Item 1. Business.

Unless

otherwise stated or the context requires otherwise, references in this annual report on Form 10-K to “SunHydrogen”, the “Company”,

“we”, “us”, or “our” refer to SunHydrogen, Inc.

Overview

At

SunHydrogen, our goal is to replace fossil fuels with clean, renewable hydrogen.

Hydrogen

is the most abundant chemical element in the universe. When hydrogen fuel is used to power transportation and industry, the only byproduct

left behind is pure water, unlike hydrocarbon fuels such as oil, coal and natural gas that release carbon dioxide and other contaminants

into the atmosphere when used. However, naturally occurring elemental hydrogen is rare – so rare, in fact, that today over 95% of

hydrogen still comes from methane, a fossil fuel (Source: Forbes, Estimating the Carbon Footprint of Hydrogen Production). This

hydrogen is procured through steam methane reforming (SMR), a capital-intensive process that emits carbon dioxide and other harmful pollutants.

The SunHydrogen solution offers an efficient and

cost-effective way to produce truly green hydrogen using sunlight and any source of water. Our core technology is a self-contained, nanoparticle-based

hydrogen generator that mimics photosynthesis to split water molecules, resulting in hydrogen. By optimizing the science of water electrolysis

at the nano-level, we believe we have developed a low-cost method to potentially produce environmentally friendly renewable hydrogen.

We believe renewable hydrogen is the fuel of the

future, and we believe our technology potentially offers solutions to the challenges that the hydrogen future presents, including cost

of production and transportation.

Because our process only requires sunlight and

water, our technology can be installed near the point of hydrogen use. This eliminates the need for pipelines and trucks that result in

high carbon emissions and high capital investment. With a target cost of $2.50/kg., we aspire for our technology to be cost-competitive

with brown hydrogen and below the cost of clean hydrogen competitors. We believe our solution has the potential to clear a path for green

hydrogen to compete with natural gas hydrogen and gain mass market acceptance as a true replacement for fossil fuels.

Our technology is primarily developed at the University

of Iowa, through a sponsored research agreement. A longtime development partner to SunHydrogen, The University of Iowa research team has

worked over the past several years to both lead and optimize the scale-up of our nanoparticle technology.

In 2021, we made strides toward the commercialization

of our nanoparticle technology and entered agreements with two new technology development partners; InRedox in Longmont, Colorado and

SCHMID Group in Freudenstadt, Germany.

Under our agreement with InRedox, they support

the design and production of essential materials for our nanoparticle technology.

Concurrently,

SCHMID has worked to develop the process and equipment to manufacture and scale up our nanoparticle technology.

In 2021, we also successfully completed production

of 100 demonstration units of our Gen 1 technology, and added a Chief Operating Officer, Woosuk Kim, a seasoned senior operations executive

with global business management and financial market expertise spanning the U.S. and Wall Street, Europe, Asia and the Middle East.

1

We will continue working diligently with our existing

technology partners to drive our technology to commercialization while we simultaneously prepare for mass production and seek out potential

manufacturing partners for production facility, equipment design and engineering.

Market Opportunity

The global hydrogen market

is large and growing rapidly. Current fossil fuels can’t sustain future energy requirements environmentally or economically, and

hydrogen fuel technologies are being adopted across all sectors as the world moves toward renewable alternatives.

Over 110 countries have set

goals to achieve net-zero emissions by 2050, and as governments look to clean energy sources to help them meet their targets, hydrogen

is emerging as a promising solution (Source: United Nations, The race to zero emissions, and why the world depends on it). It is

estimated that nearly 25% of global energy will come from clean hydrogen alone by 2050, which could bring in a projected $2.5 trillion

in annual revenues (Source: Bank of America Securities, New Energy Behind Green Hydrogen).

In the US, California is leading

the way in hydrogen strategies, with more fuel cell passenger vehicles on the road than any other state and one of the largest hydrogen

refueling station networks in the world (Source: Sierra Nevada Ally, Hydrogen Fuel Cell Vehicles are Building Momentum in California).

Globally, over 320 green hydrogen production demonstration projects have been announced, and governments around the world have put forth

ambitious strategies to utilize hydrogen and fuel cell technologies across all sectors of the economy including transportation, feedstock

and industrial heat use (Source: International Energy Agency, Hydrogen Projects Database).

By 2050, the hydrogen market

is expected to increase tenfold compared to where it stands today (Source: The Hydrogen Council, Hydrogen, scaling up).

Existing Market Growth

According

to a Grand View Research study released in March 2021, the global hydrogen generation

market size was valued at $120.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2021 to

2028. This places the market’s projected value at $184 billion in 2028.

Among

the factors driving the global hydrogen generation market size are regulations intended to reduce sulfur content and measures to reduce

the carbon footprint. U.S. federal and state governments have adopted various programs, including the Tier 3 program, to reduce the sulfur

content in gasoline, motor oil and diesel.

Growing

demand for petroleum products from developing countries is also anticipated to drive the hydrogen generation market in the coming years.

Hydrogen is used in various refining processes including hydrocracking and hydrodesulfurization to crack bigger molecules into lighter

ones and produce more usable products.

We believe increasing demand for clean fuel energy will be

affected by:

● Stringent government regulation toward desulphurization of petroleum products

● Deteriorating crude oil quality; and

● Transportation and storage issues

Therefore, we believe our

renewable hydrogen-producing technology possesses significant early market opportunity, especially as innovation and infrastructure continue

to develop.

2

Utility Scale Hydrogen Electricity

According to a March 2013

report from NREL, a national laboratory of the U.S. Department of Energy, hydrogen can be blended into existing natural gas pipeline networks,

thus bypassing the high cost of dedicated hydrogen pipelines to use hydrogen at a large scale. If implemented with relatively low concentrations,

less than 5%–15% hydrogen by volume, this strategy of storing and delivering renewable hydrogen to markets appears to be viable

without significantly increasing risks associated with utilization of the gas blend in end-use devices (such as household appliances),

overall public safety, or the durability and integrity of the existing natural gas pipeline network (Source: NREL, Blending Hydrogen

into Natural Gas Pipeline Networks: A review of Key Issues).

Hydrogen Fuel Cell Vehicles

The auto manufacturing and

vehicle industries are among the most recognized applications for hydrogen fuel technologies. According to a 2021 study by Information

Trends, over 27,500 hydrogen fuel cell vehicles had been sold by year-end 2020 since their sales first began. Sales were held back due

to the lack of a solid hydrogen refueling infrastructure, but the numbers are projected to rise quickly, and fuel cell vehicles are gaining

momentum around the world. In the same study, Information Trends projected that close to 600,000 hydrogen fuel cell buses and minibuses

will be in service by 2035 (Source: Information Trends, Global Market for Hydrogen Fuel Cell Buses). In California, executives

from 25 multinational companies including Toyota, Hyundai, BMW, Chevron and other key players have called on Governor Gavin Newsom to

heavily invest in hydrogen infrastructure in the state (Source: Ways2H, Executives Pen Letter to Newsom Calling for Major Investments

in Hydrogen Infrastructure). Stories and projections like these suggest a promising future for fuel cell vehicles.

Our Technology

Technology for

Making Renewable Hydrogen from Sunlight and Water

Powered by

solar energy, billions of our microscopic nanoparticles split apart water at the molecular level, extracting hydrogen for use as a clean

energy source and leaving behind only clean oxygen as a byproduct. This process is similar to what happens inside a plant cell during

photosynthesis: Each Photoelectrochemically Active Heterostructures (or PAH) nanoparticle is a microscopic machine, composed of multiple

layers enabling the solar electrolysis reaction to take place.

Water Splitting

In

the process of splitting a water molecule, input energy is transferred into the chemical bonds. Essentially, manufactured hydrogen serves

as a carrier or battery-like storage of the input energy. If the input energy is from fossil fuels, such as oil and gas, then carbon fossil

fuel energy is simply transferred into hydrogen. If the input energy is renewable, such as solar or wind, then new and clean energy is

stored in hydrogen.

While

the concept of water splitting is very appealing, the following challenges must be addressed for renewable hydrogen to be commercially

viable:

3

Technology

Water electrolysis

in its simplest form is the transfer of “input electrons” in the following chemical reactions:

● Cathode (reduction): 2H2O + 2e- ® H2 + 2OH-

● Anode (oxidation): 4OH- ® O2 + 2H2O + 4 e-

From

these equations, one can deduce that if every input electron (e-) is put to work and not lost, then a maximum amount

of input electrons (i.e. energy) is transferred and stored in the hydrogen molecules (H2). Additionally, if there were

a very high number of cathode and anode reaction areas within a given volume of water, then a very high number of these reactions could

happen simultaneously throughout the medium to split each water molecule into hydrogen wherever electrons are available.

SunHydrogen PanelTM

Since

our particles are intended to mimic the natural temperature conditions of photosynthesis, they can be housed in very low-cost reactors.

To facilitate the commercial use of our self-contained particle technology, we are developing a modular system that will enable the onsite

daily production and storage of hydrogen for any time use in electricity generation.

We

refer to our potential product as the SunHydrogen Panel which is comprised of the following components:

1. The Generator Housing

– Our novel device design is the first of its kind to safely separate oxygen and hydrogen in the water splitting process without

sacrificing efficiency. This device houses the water, and the solar particles/cells and is designed with inlets and outlets for water

and gasses. Utilizing a novel ion-exchange membrane strategy for separating the oxygen side from the hydrogen side, ion transport is increased

which is the key to safely increasing solar-to-hydrogen efficiency. Our design can be scaled up and manufactured for commercial use.

2. The NanoParticle or Solar Cell - Powered

by solar energy, billions of our microscopic nanoparticle solar cells split apart water at the molecular level, extracting hydrogen for

use as a clean energy source and leaving behind only clean oxygen as a byproduct.

3. Oxygen Evolution Catalyst

- This proprietary catalyst developed at the University of Iowa lab is uniformly applied onto the solar cell or nanoparticle and efficiently

oxidize water molecule to generate oxygen gas. The oxygen evolution catalyst must be robust to withstand the long operating hours of the

hydrogen generation device to ensure long lifetime. It must be stable in alkaline, neutral and acidic environments.

4. Hydrogen Evolution

Catalyst - Necessary for collecting electrons to reduce protons for generating hydrogen gas, we have successfully integrated a low-cost

hydrogen catalyst into our generator system, successfully coating a triple junction solar cell with a catalyst comprised primarily of

ruthenium, carbon and nitrogen that can function as well as platinum, the current catalyst used for hydrogen production.

5. Coating Technologies

- Two major coating technologies were developed to protect the nanoparticles and solar cells from photocorrosion under water: A transparent

conducive coating to protect our nanoparticles and solar cells from photo corrosion and efficiently transfer charges to catalysts for

oxygen and hydrogen evolution reactions; and a polymer combination that protects the triple junction solar cells from any corrosive water

environments for long lifetime of the hydrogen generation device.

In

the process of optimizing our nanoparticles to be efficient and only during experimentation with earth abundant materials (an ongoing

process), we experimented with commercially available triple junction silicon solar cells to perform tests with our generator housing

and other components. Through this experimentation, our discovery led us to believe that we could bring a system (Gen 1) to market utilizing

these readily available cells while our nanoparticles are still being optimized. While these solar cells also absorb sunlight and produce

the necessary charge for splitting the water molecules into hydrogen and oxygen, their efficiency is low, thus we have made the strategic

decision to focus on our NanoParticle strategy (Gen 2) and use the Gen 1 hydrogen generators for proof of concept and demonstration purposes

only. We anticipate these hydrogen panels will be demonstrated in various parts of the world as further proof of concept of our technology

and to promote our nanoparticle technology that will be more efficient and economical.

4

Our

business and commercialization plan utilizes our second generation of hydrogen panels featuring the nanoparticle-based technology where

billions of autonomous solar cells are electrodeposited onto porous alumina sheets and manufactured in a roll to roll process or wafer

process and inserted into our proprietary panels. For this generation, we have received multiple patents and our target cost of hydrogen

production is $2.50 per kilogram before pressurization.

We

are working with several vendors to help commercialize and manufacture our renewable hydrogen panels that use sunlight and water to generate

hydrogen. In February 2021, we entered into a cooperation agreement with Schmid Group of Freudenstadt, Germany to design and define a

process platform that enables mass manufacturing of SunHydrogen’s Gen 2 NanoParticle hydrogen panels. In April 2021, we entered

into an agreement with InRedox of Longmont, Colorado to produce the material components needed for Gen 2 manufacturing development. Both

Schmid and InRedox work alongside the research team at the University of Iowa, a longtime technology development partner to SunHydrogen

under sponsored research agreement.

Intellectual Property

On November 14, 2011, we filed

a provisional application with the U.S. Patent and Trademark Office to protect the intellectual property rights for “Photoelectrochemically

Active Heterostructures, methods for their manufacture, and methods and systems for producing desired products.” A year later on

November 14, 2012, we filed a non-provisional application claiming priority to the provisional application. On March 14, 2017, a first

patent covering the structural design of Photoelectrochemically Active Heterostructures (PAH) was granted as United States Patent No.

9,593,053B1. A divisional application claiming priority to the foregoing applications was filed, and on April 3, 2018, a second patent

covering the method for manufacturing PAH was granted as United States Patent No. 9,593,053B2. These patents protect the Company’s

proprietary design and manufacturing method of a self-contained solar-to-hydrogen device made up of millions of solar-powered water-splitting

nanoparticles, per square centimeter. These nanoparticles are coated with a separate patent-pending protective coating that prevents corrosion

during extended periods of hydrogen production. The aim of these nanoparticles is high conversion efficiency and low cost. This patent

expires on November 14, 2032.

An important aspect of the

patented technology referred to in the preceding paragraph is the integrated structures of high-density arrays of nano-sized solar cells

as part of hydrogen production nanoparticles. The technology enables manufacturing of ultra-thin sheets for solar-to-hydrogen production,

requiring substantially less material as compared to conventional solar cells used in rooftop power applications.

On March 21, 2014, we jointly

filed a provisional application with UCSB for the “Multi-junction artificial photosynthetic cell with enhanced photovoltages.”

Thereafter, we filed a non-provisional application on March 16, 2015 and a corresponding PCT Application on March 17, 2015. These applications

cover our semiconductor designs to enhance the photovoltages of the nano-sized solar cells in the PAH structures. The semiconductor designs

stacking multiple junctions inside the PAH structures would be an efficient and economic solution for the photovoltaic and the photoelectrochemical

industries. Patents were granted in Australia in April of 2018, China and Europe in March of 2019, and in the U.S. as United States Patent

No. 10,100,415 in October of 2018. A patent application is currently pending in India. This patent expires on March 17, 2025.

On September 26, 2016, we

filed jointly with the University of Iowa a provisional application for “Integrated Membrane Solar Fuel Production Assembly”

to protect the intellectual property for our generator housing system that safely separates oxygen and hydrogen in the water-splitting

process without sacrificing efficiency. This device houses the water, the solar particles/cells and is designed with inlets and outlets

for water and gases. Utilizing a special membrane for separating the oxygen side from the hydrogen side, proton transport is increased

which is the key to safely increasing solar-to-hydrogen efficiency. On September 26, 2017, we filed a PCT Application that was later nationalized

in the U.S. on March 26, 2019. The U.S. patent application for this important invention is pending and prosecution is ongoing.

5

Strategic Partners

As

of September 1, 2021, we have renewed our sponsored research agreement with the University of Iowa, As consideration under the research

agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either

party upon 60 days prior written notice or by either party upon notice of a material breach or default which is not cured within 90 days

of receipt of written notice of such breach. This term of the research agreement runs through August 31, 2022 but may be extended upon

mutual agreement of the parties.

In

February 2021, we entered into a cooperation agreement with SCHMID Group of Freudenstadt, Germany. Due to delays associated with supply

chain challenges brought on by the Covid-19 pandemic, the cooperation agreement has been extended to fully complete the work scope with

no additional cost to the company.

In

April 2021, we entered into an additional agreement with InRedox of Longmont, Colorado to support the design and production of essential

materials for our nanoparticle technology.

Competition

Currently,

most hydrogen is produced by steam reforming of natural gas or methane. This production technology dominates due to easy availability

and low prices of natural gas. Partial oxidation of petroleum oil is second in production capacity after steam reforming of natural gas.

The third largest production technology in terms of production capacity is steam gasification of coal. The current industry is heavily

dominated by large players such as Air Products, Chemicals Inc. and Air Liquide.

Green

or renewable hydrogen can be produced through electrolyzers if the electrolyzers are powered by solar or wind energy. Several companies

of this nature have emerged in the past few years. ITM Power in England and Proton Onsite in Norway are two of the largest companies in

this industry. If not powered by solar panels or wind power, they require external electricity most likely created by coal, gas or oil.

We believe that our process when fully developed may potentially offer a competitive advantage as we anticipate it will be completely

green and renewable and utilize no external power other than the sun.

Corporate Information

We

were incorporated in the State of Nevada on February 18, 2009. Our executive offices are located at 10 E. Yanonali St., Suite 36, Santa

Barbara, CA 93101.

Employees

As of September 27, 2021,

we have 4 full-time employees and several consultants. We have not experienced any work stoppages and we consider relations with our employees

and consultants to be good. Most of our research and development work is performed by the University of Iowa, through a sponsored research

agreement, and in collaboration with our development partners SCHMID and InRedox.

Item 1A. Risk Factors.

Risks related to our

business and industry

Our limited operating

history does not afford investors a sufficient history on which to base an investment decision.

We

were formed in February 2009 and are currently developing a new technology that has not yet gained market acceptance. There can be no

assurance that we will ever operate profitably or that we will have adequate working capital to meet our obligations as they become due.

6

Investors

must consider the risks and difficulties frequently encountered by early stage companies, particularly in rapidly evolving markets. Such

risks include the following:

● competition;

● need for acceptance of products;

● ability to continue to develop and extend brand identity;

● ability to anticipate and adapt to a competitive market;

● ability to effectively manage rapidly expanding operations;

● dependence upon key personnel.

We

cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event that we

do not successfully address these risks, our business, prospects, financial condition, and results of operations could be materially and

adversely affected and we may have to curtail our business.

We have a history

of losses and have never realized revenues to date. We expect to continue to incur losses and no assurance can be given that we will realize

revenues. Accordingly, we may never achieve and sustain profitability.

As

of June 30, 2021, we have an accumulated deficit of $172,976,952. For the year ended June 30, 2021 we incurred a net loss of $81,498,123.

We expect to continue to incur net losses until we are able to realize revenues to fund our continuing operations. We may fail to achieve

any or significant revenues from sales or achieve or sustain profitability. Accordingly, there can be no assurance of when, if ever,

we will be profitable or be able to maintain profitability.

We

have historically raised funds through various capital raising transactions. We will require additional funds in the future to fund our

business plans, either through additional equity or debt financings or collaborative agreements or from other sources. We have no commitments

to obtain such additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all.

In the event we are unable to obtain additional financing, we may be unable to implement our business plan. Even with such financing,

we have a history of operating losses and there can be no assurance that we will ever become profitable.

We may be unable

to manage our growth or implement our expansion strategy.

We may not be able to develop

our product or implement the other features of our business strategy at the rate or to the extent presently planned. Our projected growth

will place a significant strain on our administrative, operational and financial resources. If we are unable to successfully manage our

future growth, establish and continue to upgrade our operating and financial control systems, recruit and hire necessary personnel or

effectively manage unexpected expansion difficulties, our financial condition and results of operations could be materially and adversely

affected.

We may not be able

to successfully develop and commercialize our technologies which would result in continued losses and may require us to curtail or cease

operations.

In

early-to-mid , we entered into agreements with development partners InRedox and SCHMID Group, who are working alongside the University

of Iowa research team to take the lab-scale prototypes of our nanoparticle technology to larger, commercial-scale prototypes. However,

we have not completed a large-scale commercial prototype of our technology and are uncertain at this time when completion of a commercial

scale prototype will occur. Although the lab scale prototype demonstrates the viability of our technology, there can be no assurance that

we will be able to commercialize our technology.

7

Our revenues will

be dependent upon acceptance of our products by the market; the failure of which would cause us to curtail or cease operations.

We

believe that virtually all of our revenues will come from the sale or license of our products. As a result, we will continue to incur

substantial operating losses until such time as we are able to develop our product and generate revenues from the sale or license of our

products. There can be no assurance that businesses and customers will adopt our technology and products, or that businesses and prospective

customers will agree to pay for or license our products. Our technology and product, when fully developed, may not gain market acceptance

due to various factors such as not enough cost savings between our method of producing hydrogen and other more conventional methods. In

the event that we are not able to significantly increase the number of customers that purchase or license our products, or if we are unable

to charge the necessary prices or license fees, our financial condition and results of operations will be materially and adversely affected.

We anticipate that

we will face intense competition, and many of our competitors have substantially greater resources than we do.

We

operate in a competitive environment that is characterized by price fluctuation and technological change. We anticipate that we will compete

with major international and domestic companies. Some of our current and future potential competitors may have greater market recognition

and customer bases, longer operating histories and substantially greater financial, technical, marketing, distribution, purchasing, manufacturing,

personnel and other resources than we do. In addition, competitors may be developing similar technologies with a cost similar to, or lower

than, our projected costs. As a result, they may be able to respond more quickly to changing customer demands or to devote greater resources

to the development, promotion and sales of solar and solar-related products than we can.

Our

business plan relies on sales of our products based on either a demand for truly renewable clean hydrogen or economically produced clean

hydrogen. If we fail to compete successfully, our business would suffer and we may lose or be unable to gain market share. Neither the

demand for our product nor our ability to manufacture at commercial scale have yet been proven.

Because our industry

is highly competitive and has low barriers to entry, we may lose market share to larger companies that are better equipped to weather

a deterioration in market conditions due to increased competition.

Our

industry is highly competitive and fragmented, subject to rapid change and has low barriers to entry. We may, in the future, compete for

potential customers with solar and heating companies and other providers of solar power equipment or electric power. Some of these competitors

may have significantly greater financial, technical and marketing resources and greater name recognition than we have.

We

believe that our ability to compete depends in part on a number of factors outside of our control, including:

● the price at which others offer comparable services and equipment;

● the extent of our competitors’ responsiveness to customer needs; and

● installation technology.

Currently, competing methods

of hydrogen production include steam reforming of natural gas or methane, which dominates due to its easy availability and low price;

partial oxidation of petroleum oil; steam gasification of coal; and electrolyzers powered by solar or wind energy. There can be no assurance

that we will be able to compete successfully against current and future competitors. If we are unable to compete effectively, or if competition

results in a deterioration of market conditions, our business and results of operations would be adversely affected.

8

Our business depends

on proprietary technology that we may not be able to protect and may infringe on the intellectual property rights of others.

Our success will depend, in

part, on our technology’s commercial viability and on the strength of our intellectual property rights. We currently hold patents

in the US, China and Australia, but still have several patents pending in multiple countries. There is no guarantee the pending

patents will be granted. In addition, any agreements we enter into with our employees, consultants, advisors, customers and strategic

partners will contain restrictions on the disclosure and use of trade secrets, inventions and confidential information relating to our

technology may not provide meaningful protection in the event of unauthorized use or disclosure.

Third

parties may assert that our technology, or the products we, our customers or partners commercialize using our technology, infringes upon

their proprietary rights. We have yet to complete an infringement analysis and, even if such an analysis were available at the current

time, it is virtually impossible for us to be certain that no infringement exists, particularly in our case where our products have not

yet been fully developed.

We

may need to acquire licenses from third parties in order to avoid infringement. Any required license may not be available to us on acceptable

terms, or at all.

We

could incur substantial costs in defending ourselves in suits brought against us for alleged infringement of another party’s intellectual

property rights as well as in enforcing our rights against others, and if we are found to infringe, the manufacture, sale and use of our

or our customers’ or partners’ products could be enjoined. Any claims against us, with or without merit, would likely be time-consuming,

requiring our management team to dedicate substantial time to addressing the issues presented. Furthermore, the parties bringing claims

may have greater resources than we do.

We do not maintain

theft or casualty insurance and only maintain modest liability and property insurance coverage and therefore, we could incur losses as

a result of an uninsured loss.

We

do not maintain theft, casualty insurance, or property insurance coverage. We cannot assure that we will not incur uninsured liabilities

and losses as a result of the conduct of our business. Any such uninsured or insured loss or liability could have a material adverse effect

on our results of operations.

If we lose key

employees and consultants or are unable to attract or retain qualified personnel, our business could suffer.

Our success is highly dependent

on our ability to attract and retain qualified scientific, engineering and management personnel. We are highly dependent on our CEO, Timothy

Young, and our development team at the University of Iowa. The loss of this valuable resource could have a material adverse effect

on our operations. There can be no assurance that they will remain associated with us. Our management’s efforts will be critical

to us as we continue to develop our technology and as we attempt to transition from a development stage company to a company with commercialized

products and services. If we were to lose Mr. Young or the services of the development team at the university or any other key employees

or consultants, we may experience difficulties in competing effectively, developing our technology and implementing our business strategies.

The loss of strategic

alliances used in the development of our products and technology could impede our ability to complete our product and result in a material

adverse effect causing the business to suffer.

We

pursue strategic alliances with other companies in areas where collaboration can produce technological and industry advancement. We

have entered into a sponsored research agreement with the University of Iowa which is set to terminate August 31, 2022. If we are unable

to extend the terms of this agreement, we could suffer delays in product development or other operational difficulties which could have

a material adverse effect on our results of operations.

9

The COVID-19 pandemic may negatively affect

our operations.

The

COVID-19 pandemic is having widespread, rapidly evolving, and unpredictable impacts on global society, economies, financial markets, and

business practices. The continuing impacts of COVID-19 are highly unpredictable and could be significant, and may have an adverse effect

on our business, operations and our future financial performance.

The

impact of the pandemic on our business, operations and future financial performance could include, but is not limited to, that:

● We may experience delays in our product development;

Risks relating to

our common stock

There is a limited

trading market for our common stock.

Our common stock is not listed

on any national securities exchange. Accordingly, investors may find it more difficult to buy and sell our shares than if our common stock

was traded on an exchange. Although our common stock is quoted on the OTC Pink, it is an unorganized, inter-dealer, over-the-counter market

which provides significantly less liquidity than the Nasdaq Capital Market or other national securities exchange. Further, there is limited

trading in our common stock. These factors may have an adverse impact on the trading and price of our common stock.

Our common stock

could be subject to extreme volatility.

The

trading price of our common stock may be affected by a number of factors, including events described in the risk factors set forth in

this report, as well as our operating results, financial condition and other events or factors. In addition to the uncertainties relating

to future operating performance and the profitability of operations, factors such as variations in interim financial results or various,

as yet unpredictable, factors, many of which are beyond our control, may have a negative effect on the market price of our common stock.

In recent years, broad stock market indices, in general, and smaller capitalization companies, in particular, have experienced substantial

price fluctuations. In a volatile market, we may experience wide fluctuations in the market price of our common stock and wide bid-ask

spreads. These fluctuations may have a negative effect on the market price of our common stock. In addition, the securities market has,

from time to time, experienced significant price and volume fluctuations that are not related to the operating performance of particular

companies. These market fluctuations may also materially and adversely affect the market price of our common stock.

We anticipate that our issuance of common

stock upon conversion of outstanding convertible notes will result in dilution to our stockholders.

As of June 30, 2021, we have

outstanding $1,271,200 in convertible notes that are convertible into common stock at variable conversion prices (see Note 5 to the financial

statements included in this report). We anticipate that our issuance of common stock upon conversion of outstanding convertible notes

will result in dilution to holders of our common stock, which may have a negative effect on the price of our common stock. In addition,

as of June 30, 2021, we have outstanding warrants to purchase 94,895,239 shares of common stock and options to purchase 182,853,174 shares

of common stock, and our issuance of shares of common stock upon exercise of outstanding warrants or options may result in additional

dilution to our stockholders.

10

We have never paid

common stock dividends and have no plans to pay dividends in the future, as a result our common stock may be less valuable because a return

on an investor’s investment will only occur if our stock price appreciates.

Holders

of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid

no cash dividends on our shares of common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future.

We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any return investors in our common

stock will be in the form of appreciation in the market value of our shares of common stock, which may not occur.

Our common stock

is subject to the SEC’s penny stock rules.

Unless

our common stock is listed on a national securities exchange, including the Nasdaq Capital Market, or we have stockholders’ equity

of $5,000,000 or less and our common stock has a market price per share of less than $5.00, transactions in our common stock will be subject

to the SEC’s “penny stock” rules. If our common stock remains subject to the “penny stock” rules promulgated

under the Securities Exchange Act of 1934, broker-dealers may find it difficult to effectuate customer transactions and trading activity

in our securities may be adversely affected.

In

accordance with these rules, broker-dealers participating in transactions in low-priced securities must first deliver a risk disclosure

document that describes the risks associated with such stocks, the broker-dealer’s duties in selling the stock, the customer’s

rights and remedies and certain market and other information. Furthermore, the broker-dealer must make a suitability determination approving

the customer for low-priced stock transactions based on the customer’s financial situation, investment experience and objectives.

Broker-dealers must also disclose these restrictions in writing to the customer, obtain specific written consent from the customer, and

provide monthly account statements to the customer. The effect of these restrictions will probably decrease the willingness of broker-dealers

to make a market in our common stock, decrease liquidity of our common stock and increase transaction costs for sales and purchases of

our common stock as compared to other securities. Our management is aware of the abuses that have occurred historically in the penny stock

market.

This

may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.

Our articles of incorporation allow for

our board to create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights

of the holders of our common stock.

Our board of directors has

the authority to fix and determine the relative rights and preferences of preferred stock. Our board of directors has the authority to

issue up to 5,000,000 shares of our preferred stock without further stockholder approval. As a result, our board of directors could authorize

the issuance of a series of preferred stock that would grant to holders of preferred stock the right to our assets upon liquidation, or

the right to receive dividend payments before dividends are distributed to the holders of common stock. In addition, our board of directors

could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or that is convertible

into our common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.

Additional stock offerings in the future

may dilute then-existing shareholders’ percentage ownership of the Company.

Given our plans and expectations

that we will need additional capital and personnel, we anticipate that we will need to issue additional shares of common stock or securities

convertible or exercisable for shares of common stock, including convertible preferred stock, convertible notes, stock options or warrants.

We anticipate that our issuance of additional common stock or securities convertible into or exercisable into common stock in the future

will dilute the percentage ownership of then current stockholders.

Item 2. Properties.

Our

principal office address is 10 E. Yanonali St., Suite 36, Santa Barbara, CA, 93101. We believe that our current premises are sufficient

to handle our administrative activities for the near future as adequate lab space and equipment is attained through our agreement with

the University of Iowa.

Item 3. Legal Proceedings.

We

are not currently a party to, nor is any of our property currently the subject of, any material legal proceedings.

Item 4. Mine Safety Disclosures.

Not Applicable.

11

PART II

Item 5. Market for Registrant’s Common

Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our

common stock is quoted on the OTC Pink under the symbol “HYSR”

Common Stock

Our

Articles of Incorporation, as amended, authorizes the issuance of 5,000,000,000 shares of common stock, $0.001 par value per share and

5,000,000 shares of preferred stock, par value $0.001 per share.

All

outstanding shares of common stock are of the same class and have equal rights and attributes. The holders of our common stock are

entitled to one vote per share on all matters submitted to a vote of our stockholders. All stockholders are entitled to share equally

in dividends, if any, as may be declared from time to time by the Board of Directors out of funds legally available. In the event of liquidation,

the holders of our common stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders

do not have cumulative or preemptive rights.

As of October 2, 2021, our

common stock was held by approximately 75 stockholders of record.

Dividend Policy

We

have never declared or paid any cash dividends on our common stock. We do not anticipate paying any cash dividends to stockholders in

the foreseeable future. In addition, any future determination to pay cash dividends will be at the discretion of the Board of Directors

and will be dependent upon our financial condition, results of operations, capital requirements, and such other factors as the Board of

Directors deem relevant. There are no restrictions in our articles of incorporation or bylaws that restrict us from declaring dividends.

Equity Compensation

Plan Information

On January 23, 2019, our Board

adopted the Company’s 2019 Equity Incentive Plan (the “Plan”). The stated purpose of the Plan is to promote the success

of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain

and reward selected employees and other eligible persons. The maximum number of shares of the Company’s common stock that can be

issued under the Plan is 300,000,000.

The following table sets forth information

about our equity compensation plans as of June 30, 2021.

(a) (b)

Source: SEC EDGAR (public domain) · 10-K for the period ended 2021-06-30, filed 2021-10-08 · accession 0001213900-21-052059

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 20 headings are on that chain and 15 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.